William Blair & Company
NVAX icon

William Blair & Company’s Novavax NVAX Stock Holding History

William Blair & Company’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-524
Closed -$53K – 2060
2013
Q4 		$53K Sell
524
-375
-42% -$26.5K ﹤0.01% 1947
2013
Q3 		$56K Hold
899
– – ﹤0.01% 1981
2013
Q2 		$37K Buy
+899
New +$39K ﹤0.01% 1927

Other funds holding NVAX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

William Blair & Company's NVAX Position: Q1 2014 in Review

William Blair & Company sold out of Novavax (NVAX) in Q1 2014, closing a stake of 524 shares — an estimated $53K sold.

William Blair & Company first reported a position in NVAX in Q2 2013 and held it in 3 quarters. The position peaked at $56K in Q3 2013. 141 funds tracked by Wall St. Rank hold NVAX as of Q1 2014.

  • William Blair & Company reported no remaining Novavax position as of Q1 2014 after selling out during the quarter.
  • William Blair & Company sold 524 Novavax shares in Q1 2014, an estimated $53K.
  • William Blair & Company first reported a position in Novavax in Q2 2013 and held it in 3 quarters.
  • William Blair & Company's Novavax position peaked at $56K in Q3 2013.
  • 141 funds tracked by Wall St. Rank held Novavax as of Q1 2014.

Based on William Blair & Company's 13F filing for Q1 2014, filed 6 May 2014.